Companies / Atyr Pharma Inc / Activity
Activity — Atyr Pharma Inc
19 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Denyes Nancy Executive | Sell | Common Stock | $1.1K | -1K -3.26% | 33,124 0.03% of shares | low |
| Feb 4, 2026 | Broadfoot Jill Marie Executive | Sell | Common Stock | $1.5K | -2K -4.01% | 37,296 0.04% of shares | low |
| Feb 4, 2026 | Shukla Sanjay CEO | Sell | Common Stock | $3.7K | -4K -2.38% | 153,553 0.16% of shares | low |
| May 27, 2026 | Schimmel Paul Director | Buy | Common Stock | $49.6K | +100K +14.72% | 779,143 0.79% of shares | low |
| May 11, 2026 | Lucas Svetlana Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Gross Jane A Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Benevich Eric Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Zaknoen Sara Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Coughlin Timothy Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| May 11, 2026 | Schimmel Paul Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.05% of shares | low |
| Feb 3, 2026 | Shukla Sanjay CEO | Exercise | Restricted Stock Unit | — | -10K -100.00% | 0 0.00% of shares | low |
| Feb 3, 2026 | Shukla Sanjay CEO | Exercise | Common Stock | — | +10K +7.06% | 157,298 0.16% of shares | low |
| Jan 9, 2026 | Shukla Sanjay CEO | Grant | Employee Stock Option (right to buy) | — | +1.5M | 1,500,000 1.53% of shares | low |
| Feb 3, 2026 | Denyes Nancy Executive | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| Feb 3, 2026 | Denyes Nancy Executive | Exercise | Common Stock | — | +3K +8.52% | 34,242 0.03% of shares | low |
| Jan 9, 2026 | Denyes Nancy Executive | Grant | Employee Stock Options (right to buy) | — | +413K | 412,500 0.42% of shares | low |
| Feb 3, 2026 | Broadfoot Jill Marie Executive | Exercise | Restricted Stock Unit | — | -4K -100.00% | 0 0.00% of shares | low |
| Feb 3, 2026 | Broadfoot Jill Marie Executive | Exercise | Common Stock | — | +4K +10.68% | 38,854 0.04% of shares | low |
| Jan 9, 2026 | Broadfoot Jill Marie Executive | Grant | Employee Stock Option (right to buy) | — | +413K | 412,500 0.42% of shares | low |